NUAK2 and hepatocellular carcinoma: Consequently, NUAK2 facilitates HCV replicative potential and allows pro-fibrogenic TGF-β signaling, which accelerates hepatic fibrosis progression and eventually causes hepatocellular carcinoma [36].